Diagnostic Testing Services

The clinical diagnostic testing services support and accelerate the market entry of new drugs, vaccines and antivirals, and assist in pre- and post marketing surveillance programs.


Assay Development Services

Assay innovation and the introduction of new tools keep analysis up to date with the increasingly demanding criteria for developing new therapeutic and prophylactic candidates up to market registration.


Clinical Trial Operation Services

The clinical trial operations department provide better logistics support for the pharmaceutical, biotechnology, and medical device industries and gives Viroclinics the opportunity to monitor the quality from the moment the sample is taken to the final test results.


Quality Assurance Department

Viroclinics has adopted a high quality standard in all operations, testing procedures and reporting. The quality management system is based on NEN-EN-ISO 15189, expanded with elements of GCP and GLP, to comply with regulatory requirements and facilitate regulatory submissions.


Pre-clinical Services

Preclinical services include testing of efficacy, safety, PK and (immune) toxicology of drugs, antibodies, vaccines and antivirals targeting viral infectious diseases. The BSL-2 and BSL-3 facilities enable complicated experiments with highly pathogenic viruses.


Virus Discovery

Viroclinics participates in global surveillance programs to monitor and characterize novel virus threats to human and animal health (EMPERIE; EU FP-7). Additional research programs focus on genomics, discovery of biomarkers, correlates of protection and viral reference strain development.




Viroclinics Biosciences is a leading diagnostic and clinical trial operation service company providing diagnostic and preclinical studies along with drug development for prevention and treatment of virus infections.

Our mission is to improve human and animal health by serving the biopharmaceutical industry with state-of-the-art diagnostics, operational and logistical services, custom-made models in preclinical and clinical drug testing, and expert advice on development of antivirals and vaccines. We offer a full range of virology services for new drug development programs and post-marketing surveillance of existing drugs and vaccines, ranging from traditional virology assays to the latest deep sequencing protocols for a very broad range of viruses.


Our BSL2 and BSL3 labs enable us to perform analysis according to international ISO 15189 accreditation expanded with elements of GLP and GCP. The ongoing, intimate interaction between scientists at the Erasmus MC and company staff yields a strong, flourishing platform to act and implement assays at the forefront of Viroscience.


Latest Press Release

Meet Viroclinics at the world’s leading pharmaceutical networking event

September 24th, 2014 in ROTTERDAM, THE NETHERLANDS – Viroclinics Biosciences will be present at booth number 1G45 of the CPhI Worldwide which hosts 2,500 exhibitors and 35,000 attendees from 140 countries. This event will take place 7-9 October 2014 at the Paris Nord Villepinte in France.


Latest Publications

Clinical validation, Preclinical Animal models, Vaccine and Antiviral studies

  • Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge.
  • Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture.
  • Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.
  • Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: A model to study intervention strategies.
  • Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.




We Need You!

Job opportunities

At the moment we have no vacancies, but we are always open to contact other highly qualified and motivated individuals too. If you have completed a relevant education, have experience within the health and life sciences industry, and you would like to work in a dynamic contract research organization, please let us know.

You are invited to send an open application letter and curriculum vitae to This email address is being protected from spambots. You need JavaScript enabled to view it..